GO:0010043 response to zinc ion: Cellular Stress Response, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0010043 (response to zinc ion) describes any process that changes a cell or organism's state or activity in response to a zinc ion stimulus, including movement, secretion, enzyme production, and gene expression [2, 6].
• Zinc ion exposure triggers large-scale transcriptional reprogramming, antioxidant defense, and ion-homeostasis networks in organisms ranging from Paramecium to plants and mammals [2, 6].
• Disruption of zinc homeostasis is linked to cancer, neurodegeneration, and immune dysfunction, making this GO term a high-value target for therapeutic research [1, 4, 7].
• Zinc-based nanomaterials and zinc-organic frameworks are emerging tools that exploit zinc ion stress to induce PANoptosis, chemodynamic therapy, and tissue repair [1, 4, 7].
• Key genes in this response include metallothioneins, ZIP/SLC39 and ZnT/SLC30 transporters, MTF-1, and antioxidant enzymes such as catalase and superoxide dismutase [2, 6].
• CRISPR knockout, point-mutation, knock-in, and overexpression models are essential for causally testing zinc-response genes in disease and biotechnology contexts [1, 4, 7].
Description
GO:0010043, response to zinc ion, is a biological_process term in the Gene Ontology that covers any process resulting in a change in state or activity of a cell or an organism as a result of a zinc ion stimulus. This includes changes in movement, secretion, enzyme production, and gene expression. The term is central to understanding how organisms sense and adapt to fluctuations in zinc, an essential trace element that is also toxic in excess [2, 6]. Zinc ion exposure has been shown to drive extensive transcriptome remodeling and antioxidant biomarker responses in the unicellular eukaryote Paramecium, revealing conserved stress-coping mechanisms. In plants such as Nicotiana benthamiana, zinc ion treatment mediates resistance to tobacco mosaic virus through transcriptional reprogramming. In mammalian systems, zinc ion dyshomeostasis is increasingly recognized as a driver of disease, and engineered zinc-based nanomaterials are being developed to deliberately trigger zinc stress for cancer immunotherapy and tissue regeneration [1, 4, 7]. Researchers studying this term need reliable gene-editing models to dissect which genes causally mediate zinc responses, and this article provides a structured, citation-backed overview of the ontology, mechanisms, key genes, disease links, and research methods for GO:0010043.
response to zinc ion At A Glance
| GO ID | GO:0010043 |
|---|---|
| GO term | response to zinc ion |
| Ontology | biological_process |
| Synonym | response to zinc |
| Definition | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a zinc ion stimulus. |
| Major function | Detection and adaptive or toxicological response to zinc ion exposure, including transcriptional, antioxidant, and ion-homeostasis changes |
| Example organisms | Paramecium, Nicotiana benthamiana, mammalian cells |
| Related processes | Antioxidant response, metal ion homeostasis, stress response, immune activation |
| Research relevance | Cancer therapy, neurodegeneration, plant immunity, nanomedicine, ion interference therapy |
What Is GO:0010043?
In our own words, GO:0010043 (response to zinc ion) is the collection of biological processes by which a cell or organism detects a zinc ion stimulus and changes its state or activity in response. This can include altered gene expression, enzyme production, secretion, movement, and metabolic adjustments. The term is agnostic to whether the zinc stimulus is beneficial, adaptive, or toxic; it simply captures the response. It is a biological_process term, and its synonym is response to zinc.
Why Is response to zinc ion Important in Cell Biology?
GO:0010043 is important because zinc is both an essential micronutrient and a potential toxin, and the cellular response to zinc ion determines whether cells adapt, survive, or die. Zinc ion exposure reprograms transcription and antioxidant defenses in diverse organisms [2, 6], and zinc dyshomeostasis is implicated in cancer, neurodegeneration, and immune disorders [1, 4, 7]. Understanding this response enables the rational design of zinc-based therapeutics, including nanoparticles that induce PANoptosis for immunotherapy and zinc-organic frameworks that accelerate tissue repair [1, 4, 7].
• Zinc ion exposure triggers genome-wide transcriptional changes and antioxidant biomarker responses in Paramecium, providing a model for conserved stress responses.
• In Nicotiana benthamiana, zinc ion treatment mediates plant resistance to tobacco mosaic virus through transcriptome reprogramming.
• Zinc dyshomeostasis is a driver of cancer, and zinc-based ROS amplifiers can trigger chemodynamic and ion interference therapy.
• Bimetallic peroxide nanoparticles disrupt ion homeostasis and induce PANoptosis, linking zinc ion stress to enhanced immunotherapy.
• Zinc-organic framework-based nanozymes accelerate spinal cord injury recovery, showing the regenerative potential of zinc ion modulation.
• The reductive stress response is structurally and mechanistically linked to zinc and metal homeostasis, with implications for cell survival.
• Voltage-gated proton channels are involved in zinc and ion homeostasis, highlighting the interplay between zinc and membrane transport.
• Zinc-ion batteries are an energy storage application of zinc ion chemistry, showing the broad relevance of zinc ion research.
• CRISPR models of zinc-response genes can reveal causal roles in disease and enable target validation [1, 4, 7].
• Zinc ion response pathways are candidate biomarkers and therapeutic targets in oncology and regenerative medicine [1, 4, 7].
What Happens During response to zinc ion?
Zinc ion sensing and immediate transcriptional reprogramming
In simple terms: When cells encounter extra zinc, they quickly switch many genes on or off to cope with it.
Zinc ion exposure rapidly changes the transcriptional landscape of cells. In the unicellular eukaryote Paramecium, comparative transcriptome analysis after zinc ion exposure revealed coordinated changes in gene expression and antioxidant biomarkers, indicating a broad stress-coping program. Similarly, in Nicotiana benthamiana, zinc ion treatment reprogrammed the transcriptome and mediated resistance to tobacco mosaic virus, demonstrating that zinc ion sensing is coupled to defense gene expression. These responses are part of GO:0010043 because they represent changes in gene expression and enzyme production as a result of a zinc ion stimulus.
Antioxidant defense and redox balancing
In simple terms: Zinc stress can cause oxidative stress, so cells boost their antioxidant enzymes to protect themselves.
Zinc ion exposure is often accompanied by oxidative stress, and cells respond by upregulating antioxidant systems. In Paramecium, antioxidant biomarker responses were measured alongside transcriptome changes, showing that zinc ion exposure activates redox-protective pathways. The reductive stress response is structurally and mechanistically linked to metal homeostasis, and its regulation is critical for surviving zinc and other metal stresses. These antioxidant and redox-balancing events are integral to the response to zinc ion.
Ion homeostasis and transport regulation
In simple terms: Cells adjust the gates and pumps that control zinc and other ions to keep internal levels safe.
Maintaining zinc homeostasis requires coordinated regulation of zinc transporters and ion channels. Bimetallic peroxide nanoparticles disrupt ion homeostasis, and this disruption is part of the cellular response to zinc ion stress. Voltage-gated proton channels contribute to ion homeostasis and pH regulation, which intersect with zinc ion responses. In plants, zinc ion-mediated resistance involves ion and defense signaling networks. These transport and homeostasis adjustments are core components of GO:0010043.
Cell death and immune activation pathways
In simple terms: If zinc stress is too strong, cells can die in ways that alert the immune system.
Severe zinc ion stress can trigger regulated cell death and immune activation. Bimetallic peroxide nanoparticles induce PANoptosis by disrupting ion homeostasis, linking zinc ion stress to inflammatory cell death and enhanced immunotherapy. Zinc-based ROS amplifiers trigger cancer chemodynamic and ion interference therapy through self-cascade catalysis, showing that zinc ion stress can be harnessed to kill cancer cells. These death and immune pathways are downstream outcomes of the response to zinc ion.
Tissue repair and regenerative signaling
In simple terms: Controlled zinc ion responses can help tissues heal and regenerate.
Zinc ion modulation can promote tissue repair. Engineered multifunctional zinc-organic framework-based aggregation-induced emission nanozymes accelerate spinal cord injury recovery, indicating that zinc ion-related responses can be directed toward regeneration. This regenerative signaling is a beneficial outcome of the response to zinc ion and expands the therapeutic scope of GO:0010043.
Key Genes Involved in GO:0010043 response to zinc ion
The following genes and proteins are representative of the response to zinc ion (GO:0010043), based on the verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| MTF-1 | Metal-responsive transcription factor controlling metallothionein and zinc homeostasis genes | Central regulator of transcriptional response to zinc ion [2, 6] |
| MT1 | Metallothionein, zinc-binding and antioxidant protein | Biomarker of zinc ion exposure and antioxidant defense [2, 6] |
| MT2 | Metallothionein isoform involved in zinc buffering | Zinc ion stress response and redox balance [2, 6] |
| SLC39A1 (ZIP1) | Zinc influx transporter | Zinc ion uptake and homeostasis [1, 5] |
| SLC30A1 (ZnT1) | Zinc efflux transporter | Zinc ion detoxification and homeostasis [1, 5] |
| CAT | Catalase, antioxidant enzyme | Antioxidant biomarker response to zinc ion |
| SOD1 | Superoxide dismutase 1, antioxidant enzyme | Redox protection during zinc ion exposure [2, 3] |
| GPX1 | Glutathione peroxidase 1 | Antioxidant defense in zinc ion response |
| NQO1 | NAD(P)H quinone dehydrogenase 1 | Reductive stress and antioxidant response |
| NFE2L2 (NRF2) | Master antioxidant transcription factor | Regulates antioxidant genes during zinc ion stress [2, 3] |
| HIF1A | Hypoxia-inducible factor 1 alpha | Ion homeostasis and stress adaptation [1, 7] |
| TNF | Tumor necrosis factor, inflammatory cytokine | Immune activation after zinc ion-induced PANoptosis |
| IL6 | Interleukin 6, inflammatory cytokine | Immune response to zinc ion stress |
| CASP3 | Caspase 3, apoptosis executioner | Cell death downstream of zinc ion stress [1, 7] |
| GSDMD | Gasdermin D, pyroptosis effector | PANoptosis and immune activation |
| MLKL | Mixed lineage kinase domain like pseudokinase, necroptosis effector | PANoptosis induction by zinc ion disruption |
| HVCN1 | Voltage-gated proton channel | Ion homeostasis and pH regulation |
| PRDX1 | Peroxiredoxin 1 | Reductive stress response and antioxidant defense |
How Is response to zinc ion Regulated?
The response to zinc ion (GO:0010043) is regulated at multiple levels. Transcriptional control is mediated by metal-responsive transcription factors such as MTF-1, which activate metallothionein and zinc transporter genes upon zinc ion exposure [2, 6]. Antioxidant and reductive stress pathways, including NRF2 and the reductive stress response machinery, modulate the cellular redox state during zinc stress. Ion homeostasis is maintained by zinc transporters (ZIP/SLC39 and ZnT/SLC30 families) and ion channels such as voltage-gated proton channels [1, 5]. In disease contexts, zinc-based nanomaterials can deliberately disrupt ion homeostasis to trigger PANoptosis and immune activation, showing that the response can be therapeutically regulated [1, 7].
response to zinc ion and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| MTF-1 | Zinc homeostasis and stress response | Knockout and point-mutation models in cell lines [2, 6] |
| MT1 | Antioxidant defense and metal toxicity | Overexpression and knockout models [2, 6] |
| SLC30A1 (ZnT1) | Zinc efflux and cancer | Knock-in and knockout models [1, 5] |
| NQO1 | Reductive stress and metabolic disease | Point-mutation and overexpression models |
| GSDMD | PANoptosis and immunotherapy | Knockout models in cancer cells |
Cancer and ion interference therapy
Zinc ion dyshomeostasis is exploited in cancer therapy. Zinc-based ROS amplifiers trigger chemodynamic and ion interference therapy through self-cascade catalysis, killing cancer cells by disrupting ion homeostasis. Bimetallic peroxide nanoparticles induce PANoptosis by disrupting ion homeostasis, which enhances immunotherapy. These studies link GO:0010043 to cancer treatment and immune activation.
Neurodegeneration and spinal cord injury
Zinc ion imbalance is relevant to neurological injury and repair. Engineered zinc-organic framework-based nanozymes accelerate spinal cord injury recovery, indicating that controlled zinc ion responses can support neural regeneration. Voltage-gated proton channels contribute to ion homeostasis in excitable cells, which is relevant to neurodegeneration.
Infectious disease and plant immunity
Zinc ion treatment mediates plant resistance to tobacco mosaic virus in Nicotiana benthamiana through transcriptome reprogramming. This demonstrates that GO:0010043 is relevant to host defense and infectious disease biology beyond mammals.
Reductive stress and metabolic disorders
The reductive stress response is structurally and mechanistically linked to metal homeostasis, and its dysregulation can contribute to metabolic and degenerative disorders. Zinc ion exposure also activates antioxidant biomarkers that are relevant to oxidative stress-related diseases.
From response to zinc ion-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of MTF-1 abolish zinc-induced transcription? | MTF-1 knockout cell line [2, 6] |
| Does a point mutation in SLC30A1 alter zinc efflux? | SLC30A1 point-mutation knock-in [1, 5] |
| Can overexpression of MT1 protect against zinc toxicity? | MT1 overexpression cell line [2, 6] |
| Does tagging NQO1 reveal its localization during reductive stress? | Tagged knock-in of NQO1 |
| Does GSDMD knockout block zinc-induced PANoptosis? | GSDMD knockout cancer cells |
| Does zinc-organic framework treatment require HIF1A? | HIF1A knockout or knockdown models [4, 7] |
How to Study the response to zinc ion Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Genome-wide gene expression changes | Transcriptional response to zinc ion [2, 6] |
| Antioxidant biomarker assays | Catalase, SOD, GPX activity and oxidative stress markers | Redox response to zinc ion |
| Reductive stress assays | NAD+/NADH balance and reductive stress response | Metal stress and cell survival |
| Fluorescent zinc imaging | Intracellular zinc ion levels and dynamics | Ion homeostasis studies [1, 5] |
| Electrophysiology | Ion channel activity including proton channels | Membrane transport during zinc stress |
| Cell death assays | Apoptosis, pyroptosis, necroptosis (PANoptosis) | Zinc-induced cell death and immunotherapy [1, 7] |
| ROS measurement | Reactive oxygen species levels | Chemodynamic and ion interference therapy |
| Nanozyme activity assays | Catalytic activity of zinc-organic frameworks | Tissue repair and regeneration |
Transcriptomics and RNA-seq
RNA-seq is widely used to capture the transcriptional response to zinc ion. Comparative transcriptome analysis in Paramecium after zinc ion exposure revealed coordinated gene expression changes and antioxidant biomarker responses. Transcriptome analysis in Nicotiana benthamiana showed that zinc ion treatment reprograms defense gene expression and mediates resistance to tobacco mosaic virus. These methods directly measure the gene expression component of GO:0010043.
Antioxidant and redox assays
Antioxidant biomarker assays measure the redox component of the zinc ion response. In Paramecium, antioxidant biomarkers were quantified alongside transcriptome changes after zinc ion exposure. Reductive stress response assays can reveal how cells balance reducing equivalents during metal stress. These methods are essential for linking GO:0010043 to oxidative and reductive stress biology.
Ion homeostasis and imaging
Ion homeostasis can be monitored using fluorescent zinc probes and ion-sensitive dyes. Bimetallic peroxide nanoparticles that disrupt ion homeostasis were studied using ion homeostasis assays and cell death readouts. Voltage-gated proton channel activity, which intersects with zinc ion responses, can be measured by electrophysiology and pH imaging. These approaches localize and quantify zinc ion dynamics in live cells.
Cell death and immune activation assays
PANoptosis and immune activation are key outcomes of severe zinc ion stress. Bimetallic peroxide nanoparticles induce PANoptosis by disrupting ion homeostasis, which was assessed by cell death and immune activation assays. Zinc-based ROS amplifiers trigger chemodynamic and ion interference therapy, evaluated by cytotoxicity and ROS measurements. These methods connect GO:0010043 to therapeutic outcomes.
How CRISPR Can Be Used to Study GO:0010043 response to zinc ion
Knockout
CRISPR knockout is used to test whether a candidate gene is required for the response to zinc ion. For example, knocking out MTF-1 or metallothioneins can reveal their necessity for zinc-induced transcription and antioxidant defense [2, 6]. Knocking out GSDMD or MLKL can determine whether zinc-induced PANoptosis depends on these effectors. Knockout models provide causal evidence for gene function in GO:0010043.
Point Mutation
CRISPR point mutation introduces precise amino acid changes to dissect domain-specific functions. Point mutations in zinc transporter genes such as SLC30A1 can reveal residues required for zinc efflux and homeostasis [1, 5]. Point mutations in NQO1 can test its role in the reductive stress response. These models are valuable for separating transport, catalytic, and regulatory functions within the zinc ion response.
Knock-in
CRISPR knock-in can add tags or reporters to endogenous zinc-response genes. Tagged knock-in of MT1 or NQO1 allows real-time tracking of protein localization and dynamics during zinc ion exposure [2, 3]. Knock-in of disease-associated variants in zinc transporters can model human disorders linked to zinc dyshomeostasis [1, 5]. These models preserve endogenous regulation while enabling precise measurement.
Overexpression
CRISPR overexpression (e.g., via CRISPRa or transgenic insertion) can test gain-of-function effects. Overexpressing MT1 or antioxidant enzymes can protect cells from zinc toxicity and oxidative stress [2, 6]. Overexpressing zinc-organic framework-related targets can enhance tissue repair in spinal cord injury models. Overexpression models complement knockout studies to establish sufficiency and therapeutic potential.
How EDITGENE Supports response to zinc ion Research
Researchers studying response to zinc ion-related genes often need to determine whether a candidate gene is causally involved in zinc sensing, transport, antioxidant defense, or cell death. Observational transcriptomics can nominate genes, but causal validation requires precise genome editing. EDITGENE provides the full spectrum of CRISPR services to build knockout, point-mutation, knock-in, and overexpression cell models, as well as library screening and bioinformatics support, enabling rigorous dissection of GO:0010043 mechanisms.
Contact EDITGENE today to design your custom CRISPR model for response to zinc ion research.
Frequently Asked Questions About response to zinc ion
What is GO:0010043 response to zinc ion?
GO:0010043 is a Gene Ontology biological_process term defined as any process that results in a change in state or activity of a cell or an organism as a result of a zinc ion stimulus, including changes in movement, secretion, enzyme production, and gene expression [2, 6].
What genes are involved in the response to zinc ion?
Key genes include metallothioneins (MT1, MT2), metal-responsive transcription factor MTF-1, zinc transporters SLC39A1 and SLC30A1, antioxidant enzymes CAT, SOD1, GPX1, and cell death effectors such as GSDMD and MLKL [1, 2, 3, 5, 6].
How does zinc ion exposure affect cells?
Zinc ion exposure triggers transcriptional reprogramming, antioxidant defense, ion homeostasis adjustments, and in severe cases regulated cell death such as PANoptosis [1, 2, 6, 7].
Is the response to zinc ion involved in cancer?
Yes, zinc dyshomeostasis is exploited in cancer therapy, where zinc-based ROS amplifiers trigger chemodynamic and ion interference therapy, and bimetallic peroxide nanoparticles induce PANoptosis for enhanced immunotherapy [1, 7].
What research methods are used to study response to zinc ion?
Common methods include RNA-seq, antioxidant biomarker assays, reductive stress assays, fluorescent zinc imaging, electrophysiology, cell death assays, ROS measurement, and nanozyme activity assays [1, 2, 3, 4, 5, 7].
How can CRISPR help study GO:0010043?
CRISPR knockout, point mutation, knock-in, and overexpression models allow causal testing of zinc-response genes, while CRISPR library screening can identify novel regulators of the response [1, 2, 3, 6, 7].
What is the role of MTF-1 in the zinc ion response?
MTF-1 is a metal-responsive transcription factor that controls metallothionein and zinc homeostasis genes, making it a central regulator of the transcriptional response to zinc ion [2, 6].
Does zinc ion exposure cause oxidative stress?
Yes, zinc ion exposure is associated with oxidative stress, and cells respond by upregulating antioxidant enzymes such as catalase and superoxide dismutase [2, 3].
Can zinc ion responses be harnessed for tissue repair?
Yes, engineered zinc-organic framework-based nanozymes accelerate spinal cord injury recovery, showing that controlled zinc ion responses can support regeneration.
What diseases are linked to zinc ion dyshomeostasis?
Zinc ion dyshomeostasis is linked to cancer, neurodegeneration, spinal cord injury, infectious disease, and metabolic disorders involving reductive stress [1, 3, 4, 6, 7].
Conclusion
GO:0010043 (response to zinc ion) is a broad and biologically important Gene Ontology term that captures how cells and organisms sense and react to zinc ion stimuli. From transcriptional reprogramming and antioxidant defense to ion homeostasis and regulated cell death, the response to zinc ion is central to stress biology, immunity, and disease [1, 2, 3, 5, 6, 7]. Zinc-based nanomaterials and nanozymes are translating this biology into cancer immunotherapy and regenerative medicine [1, 4, 7]. CRISPR-based knockout, point-mutation, knock-in, overexpression, and library screening models are essential tools for causally dissecting the genes that mediate this response, and EDITGENE provides end-to-end support for such studies.
References
- 1. Hou G et al.. 2024. Bimetallic peroxide nanoparticles induce PANoptosis by disrupting ion homeostasis for enhanced immunotherapy.. Sci Adv 10(45):eadp7160 PMID: 39514658
- 2. Li C et al.. 2023. Comparative transcriptome and antioxidant biomarker response reveal molecular mechanisms to cope with zinc ion exposure in the unicellular eukaryote Paramecium.. J Hazard Mater 453:131364 PMID: 37080029
- 3. Manford AG et al.. 2021. Structural basis and regulation of the reductive stress response.. Cell 184(21):5375-5390.e16 PMID: 34562363
- 4. Zheng J et al.. 2024. Engineered Multifunctional Zinc-Organic Framework-Based Aggregation-Induced Emission Nanozyme for Accelerating Spinal Cord Injury Recovery.. ACS Nano 18(3):2355-2369 PMID: 38197586
- 5. Decoursey TE. 2012. Voltage-gated proton channels.. Compr Physiol 2(2):1355-85 PMID: 23798303
- 6. Wang J et al.. 2022. Transcriptome analysis reveals the mechanism of zinc ion-mediated plant resistance to TMV in Nicotiana benthamiana.. Pestic Biochem Physiol 184:105100 PMID: 35715039
- 7. Sun Y et al.. 2024. Zinc-Based ROS Amplifiers Trigger Cancer Chemodynamic/Ion Interference Therapy Through Self-Cascade Catalysis.. Small 20(42):e2402320 PMID: 38881259
- 8. Zhang T et al.. 2024. Poly(3, 4-Ethylenedioxythiophene) as Promising Energy Storage Materials in Zinc-Ion Batteries.. Macromol Rapid Commun 45(23):e2400476 PMID: 39470626
